LIFA Partners - Advisory & Fractional Leadership

Fractional leadership for MedTech founders

LIFA Partners helps early-stage MedTech and diagnostics companies bridge the gap between innovation and market access.We bring practical expertise in go-to-market, commercial, regulatory, and fundraising strategy, guiding founders through the milestones that matter most for investors, clinicians, and patients.

Snorri Helgason

Founding Partner

Executive operator with a decade of experience in MedTech commercialisation, market access, clinical affairs, and reimbursement.

Jón Ingi Bergsteinsson

Founder & CEO

Exited MedTech founder and ex-CTO & CCO of SMART-TRIAL, with 12+ years in clinical trials and regulatory strategy. Angel investor and founder of LIFA Ventures and the Icelandic Business Angel Network.

2 for 1. Together, we combine operational experience, investor insight, and deep MedTech networks across the Nordics, Europe, and the U.S.

We’ve founded, scaled, and exited companies in MedTech.
‍
We understand what it takes to go from prototype to regulatory approval, to first customers and beyond.Our approach is collaborative, we work as an extension of your team, helping you make the right strategic and operational decisions at the right time.

🌎 Go-to-Market & Reimbursement

We support early market analysis and research, market entry, payer engagement, and health economics to validate your commercial model.

💰 Fundraising Readiness

We help shape your investor story, aligning milestones, data, and strategy for fundraising success.

‼️ Regulatory & Clinical Pathway

We help define the right regulatory route (FDA, MDR, IVDR), build evidence strategies, and align clinical plans with reimbursement requirements.

🤝 Fractional Leadership & Board

Experienced MedTech executives who can provide strategic guidance or temporarily step in as your CEO, CTO, CCO, COO, or CRO to execute critical milestones.

About LIFA Ventures

Led by Jón Ingi Bergsteinsson - an exited MedTech founder (SMART-TRIAL), angel investor and MedTech expert. And Snorri Helgason, a MedTech executive operator, commercialisation and market access expert.

Together, we bring more than two decades of MedTech experience, combining founder perspective, clinical insight, and investor discipline to back and support the next generation of Nordic healthcare innovators.

The firm is in the process of establishing its first investment fund, LIFA Ventures Fund I, which is expected to focus on early-stage Nordic medical devices and diagnostics.

In parallel, through LIFA Partners, we provide advisory and fractional leadership to help MedTech teams strengthen regulatory, clinical, and commercial strategies before and after investment.

Partnering with MedTech founders to reach commercial success